Latest News

MEI Pharma to Present at the Jefferies Virtual Healthcare Conference
MEI Pharma to Host Investor and Analyst Video Webcast Following ASCO20 Virtual Scientific Program
MEI Pharma and Kyowa Kirin Announces ME-401 Phase 1b Study to be Highlighted in a Presentation at the Virtual Edition of the 25th European Hematology Association Annual Congress
Helsinn and MEI Pharma Announce Updated Clinical Data from the Phase 2 Study Evaluating Pracinostat in Combination with Azacitidine in Patients with High/Very-high Risk Myelodysplastic Syndromes